Podcast: Key Business Considerations for Growing BioPharm Product Pipeline
Feb 10, 2012
By BioPharm International Editors
In this first intervew with BioPharm International, Tarja Mottram, CEO of Action for Results, discusses some of the deeper business considerations for companies planning to grow with a pipeline or portfolio. Posted Feb. 2012.
Patient access to critical experimental medicines continues to grab public attention as states enact “Right-to-Try” laws and Congress eyes establishing a national policy to provide not-yet-approved therapies to terminally ill patients.